Bio-Rad's Credit Rating Raised by S&P | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Standard & Poor's today raised its corporate credit rating on Bio-Rad Laboratories to "BBB" from "BBB-" with a stable outlook.

The credit rating service also said that it had raised Bio-Rad's senior subordinated rating to "BBB-" from "BB+".

"The upgrade reflects Bio-Rad's continued solid operating performance and cash flow generation, despite recent challenges in the life science industry," S&P Credit Analyst Arthur Wong said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.